Are Medical Stocks Lagging Bayer (BAYRY) This Year?

06.02.26 15:40 Uhr

Werte in diesem Artikel
Aktien

45,75 EUR -0,45 EUR -0,97%

Indizes

PKT PKT

PKT PKT

2.105,2 PKT 18,8 PKT 0,90%

2.178,0 PKT 20,2 PKT 0,94%

24.721,5 PKT 230,4 PKT 0,94%

9.259,7 PKT 84,3 PKT 0,92%

1.990,6 PKT 22,6 PKT 1,15%

596,6 PKT -0,4 PKT -0,06%

224,1 PKT -0,1 PKT -0,06%

635,0 PKT 5,6 PKT 0,88%

5.998,4 PKT 72,7 PKT 1,23%

13.110,3 PKT 120,3 PKT 0,93%

24.716,0 PKT 315,0 PKT 1,29%

24.722,0 PKT 235,6 PKT 0,96%

18.870,6 PKT 109,2 PKT 0,58%

9.569,2 PKT 84,7 PKT 0,89%

24.731,8 PKT 292,7 PKT 1,20%

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Bayer Aktiengesellschaft (BAYRY) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Bayer Aktiengesellschaft is one of 928 companies in the Medical group. The Medical group currently sits at #10 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Bayer Aktiengesellschaft is currently sporting a Zacks Rank of #2 (Buy).Over the past 90 days, the Zacks Consensus Estimate for BAYRY's full-year earnings has moved 9.7% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.According to our latest data, BAYRY has moved about 26.2% on a year-to-date basis. At the same time, Medical stocks have gained an average of 3.1%. This means that Bayer Aktiengesellschaft is outperforming the sector as a whole this year.One other Medical stock that has outperformed the sector so far this year is Align Technology (ALGN). The stock is up 12.5% year-to-date.For Align Technology, the consensus EPS estimate for the current year has increased 1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry, a group that includes 11 individual stocks and currently sits at #200 in the Zacks Industry Rank. This group has gained an average of 1.7% so far this year, so BAYRY is performing better in this area. Align Technology, however, belongs to the Medical - Dental Supplies industry. Currently, this 15-stock industry is ranked #82. The industry has moved +8.5% so far this year.Investors with an interest in Medical stocks should continue to track Bayer Aktiengesellschaft and Align Technology. These stocks will be looking to continue their solid performance.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bayer Aktiengesellschaft (BAYRY): Free Stock Analysis Report Align Technology, Inc. (ALGN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Bayer

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Bayer

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Bayer

Wer­bung

Analysen zu Bayer

DatumRatingAnalyst
17:31Bayer OverweightBarclays Capital
09:11Bayer NeutralUBS AG
09:11Bayer BuyGoldman Sachs Group Inc.
05.02.2026Bayer OverweightJP Morgan Chase & Co.
05.02.2026Bayer OverweightBarclays Capital
DatumRatingAnalyst
17:31Bayer OverweightBarclays Capital
09:11Bayer BuyGoldman Sachs Group Inc.
05.02.2026Bayer OverweightJP Morgan Chase & Co.
05.02.2026Bayer OverweightBarclays Capital
02.02.2026Bayer OverweightJP Morgan Chase & Co.
DatumRatingAnalyst
09:11Bayer NeutralUBS AG
19.01.2026Bayer NeutralUBS AG
19.01.2026Bayer HoldJefferies & Company Inc.
16.01.2026Bayer NeutralUBS AG
12.12.2025Bayer HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
31.10.2019Bayer VerkaufenIndependent Research GmbH
21.08.2019Bayer VerkaufenIndependent Research GmbH
01.08.2019Bayer VerkaufenIndependent Research GmbH
28.06.2019Bayer VerkaufenIndependent Research GmbH
25.04.2019Bayer VerkaufenIndependent Research GmbH

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bayer nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen